跳至主要内容
临床试验/JPRN-UMIN000017775
JPRN-UMIN000017775已完成3 期

Evaluation of the safety on hemodiafilter "AMPA-01" in renal failure patients. - Evaluation of the safety on AMPA-01.

ASAHI KASEI MEDICAL CO., LTD.0 个研究点目标入组 12 人开始时间: 2015年6月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Need to blood purification other than AMPA-01. 2) With a medical history of anaphylaxis symptoms caused by polysulfone or polyvinylpyrrolidone (PVP). 3) Pregnant women or lactating mothers 4) With severe organ dysfunction other than kidney. 5) Patients who had participated in other clinical trial within the previous 6 months. 6) Judged ineligible by the attending physician.

研究者

相似试验